Pekinenin E inhibits the growth of hepatocellular carcinoma by promoting endoplasmic reticulum stress mediated cell death

14Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Hepatocellular carcinoma (HCC) is a malignant primary liver cancer with poor prognosis. In the present study, we report that pekinenin E (PE), a casbane diterpenoid derived from the roots of Euphorbia pekinensis, has a strong antitumor activity against human HCC cells both in vitro and in vivo. PE suppressed the growth of human HCC cells Hep G2 and SMMC-7721. In addition, PE-mediated endoplasmic reticulum (ER) stress caused increasing expressions of C/EBP homologous protein (CHOP), leading to apoptosis in HCC cells both in vitro and in vivo. Inhibition of ER stress with CHOP small interfering RNA or 4-phenyl-butyric acid partially reversed PE-induced cell death. Furthermore, PE induced S cell cycle arrest, which could also be partially reversed by CHOP knockdown. In all, these findings suggest that PE causes ER stress-associated cell death and cell cycle arrest, and it may serve as a potent agent for curing human HCC.

Cite

CITATION STYLE

APA

Fan, L., Xiao, Q., Chen, Y., Chen, G., Duan, J., & Tao, W. (2017). Pekinenin E inhibits the growth of hepatocellular carcinoma by promoting endoplasmic reticulum stress mediated cell death. Frontiers in Pharmacology, 8(JUN). https://doi.org/10.3389/fphar.2017.00424

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free